Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2007-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPS.2006.11.018PMID 17223022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.

  2007cited by this paper
• Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

  2006cited by this paper
• Breath Actuated Device Improves Delivery to Target Sites Beyond the Nasal Valve

  2006cited by this paper
• Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

  2005cited by this paper
• Localization and Differential Activity of P-glycoprotein in the Bovine Olfactory and Nasal Respiratory Mucosae

  2005cited by this paper
• Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.

  2005cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Clearance characteristics of chitosan based formulations in the sheep nasal cavity.

  2001cited by this paper
• Novel chitosan-based delivery systems for the nasal administration of a LHRH-analogue

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Olfactory reception in invertebrates.

  1999cited by this paper
• Evaluation of the clearance characteristics of bioadhesive systems in humans.

  1999cited by this paper
• Effects of Pharmaceutical Compounds on Ciliary Beating in Human Nasal Epithelial Cells: A Comparative Study of Cell Culture Models

  1999cited by this paper
• Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine.

  1999cited by this paper
• Intranasal insulin delivery and therapy.

  1999cited by this paper
• Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems.

  1999cited by this paper
• Effects of formulation variables on nasal epithelial cell integrity: Biochemical evaluations

  1995cited by this paper
• Scintigraphic Assessment of the Oropharyngeal and Nasal Depositions of Fusafungine from a Pressurized Inhaler and from a Novel Pump Spray Device

  1995cited by this paper
• The Distribution of an Intranasal Insulin Formulation in Healthy Volunteers: Effect of Different Administration Techniques

  1994cited by this paper
• The influence of solution viscosity on nasal spray deposition and clearance

  1988cited by this paper
• Deposition pattern of nasal sprays in man.

  1988cited by this paper
• Bioadhesive microspheres as a potential nasal drug delivery system

  1987cited by this paper
• Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.

  1986cited by this paper
• Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues

  1985cited by this paper
• Intranasal drug delivery by spray and drops

  1985cited by this paper
• Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants.

  1983cited by this paper
• Absence of relationships between L-dopa plasma levels and therapeutic effect in Parkinson's disease treated with L-dopa.

  1976cited by this paper
• Distribution and removal of human serum albumin-technetium 99m instilled intranasally.

  1976cited by this paper

• Molecular insights, challenges and progressions of polysaccharide and protein-based biopolymeric carriers for intranasal drug delivery: A review.

  2026cites this paper
• Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia.

  2026cites this paper
• Intranasal Delivery: Formulation Factors and Insights Into User Experience

  2025cites this paper
• “GEPANTS” CGPR ANTAGONIST – A NEW CLINICAL APPROACH TO TREAT MIGRAINE AND NEUROPEPTIDES

  2025cites this paper
• Nano-Based Technology in Glioblastoma

  2025cites this paper
• Maximising olfactory deposition of a valproic acid (VPA)-loaded nanostructured lipid carriers (NLC) formulation.

  2025cites this paper
• Intranasal sertraline for the investigation of nose-to-brain delivery to mitigate systemic exposure

  2025cites this paper
• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025cites this paper
• Design of Polycation-Functionalized Resveratrol Nanocrystals for Intranasal Administration

  2025cites this paper
• The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption.

  2025cites this paper
• [Effects of different surgical methods on the application of topical hormones in the sinus after operation].

  2024cites this paper
• Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024influential citation
• Intranasal therapies for neonatal hypoxic-ischemic encephalopathy: Systematic review, synthesis, and implications for global accessibility to care

  2024cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• Lipid nanocapsules: A Novel Strategy for Brain Targeting via Nasal Administration

  2024cites this paper
• Transporter targeted-carnitine modified pectin-chitosan nanoparticles for inositol hexaphosphate delivery to the colon: An in silico and in vitro approach.

  2024cites this paper
• A Hematological and Histopathological Study on Diphenhydramine Nasal Nano-gel and Nano-emulgel for the Management of Allergic Rhinitis in Animal Model

  2023cites this paper
• Transnasal-brain delivery of nanomedicines for neurodegenerative diseases

  2023cites this paper
• A REVIEW ON: DRUG DELIVERY THROUGH NASAL ROUTE

  2023influential citation
• Lamotrigine-Loaded Poloxamer-Based Thermo-Responsive Sol–Gel: Formulation, In Vitro Assessment, Ex Vivo Permeation, and Toxicology Study

  2023cites this paper
• Exploring the potential of intranasal drug delivery systems in the management of hypertension

  2023cites this paper
• Crosslinked and PEGylated Pectin Chitosan Nanoparticles for Delivery of Phytic Acid to Colon.

  2023cites this paper
• Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease.

  2023cites this paper
• Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations.

  2022cites this paper
• Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances

  2022cites this paper
• Does endoscopic balloon dilatation improve intranasal drug delivery to the olfactory cleft? A preclinical cadaver feasibility study.

  2022cites this paper
• Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluation

  2021cites this paper
• Controlled Drug Delivery via the Nasal Route

  2021cites this paper
• Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel

  2021cites this paper
• Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme

  2020cites this paper
• Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.

  2020cites this paper
• Nose-to-Brain Drug Delivery Enabled by Nanocarriers

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Buspirone loaded solid lipid nanoparticles for amplification of nose to brain efficacy: Formulation development, optimization by Box-Behnken design, in-vitro characterization and in-vivo biological evaluation

  2020cites this paper
• Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery

  2020cites this paper
• Nasal delivery nanoparticles

  2020cites this paper
• Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats

  2020cites this paper
• Modulation of nose-to-brain delivery of a P-glycoprotein (MDR1) substrate model drug (quinidine) in rats.

  2020cites this paper
• A Comparison between Mygind and Kaiteki positions in administration of drops to the olfactory cleft

  2020cites this paper
• Nasal Drug Delivery System

  2020cites this paper
• Challenges in topical therapy of chronic rhinosinusitis: The case of nasal drops application - A systematic review.

  2020cites this paper
• Delivery of Nanoparticles and Macromolecules across the Blood–Brain Barrier

  2020cites this paper
• Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis

  2019cites this paper
• Nasal drug delivery system: A innovative approach

  2019cites this paper
• Therapeutic efficacy of nanoparticles and routes of administration

  2019cites this paper
• Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

  2019cites this paper
• Efficacy of Dexamethasone Versus Fluticasone Nasal Sprays in Postoperative Patients With Chronic Rhinosinusitis With Nasal Polyps

  2019cites this paper
• A Review: Nose to Brain Drug Delivery for Various CNS Disorders

  2019cites this paper
• Butylglyceryl Pectin Nanoparticles: Synthesis, Formulation and Characterization

  2019cites this paper
• Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis

  2019cites this paper
• Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

  2019cites this paper
• 1 Nasal Drug Delivery of Anticancer Drugs for the 2 Treatment of Glioblastoma : Preclinical and Clinical 3 Trials 4

  2019cites this paper
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell

  2018cites this paper
• Intranasal drug delivery devices and interventions associated with post-operative endoscopic sinus surgery

  2018cites this paper
• Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment.

  2018cites this paper
• Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

  2018cites this paper
• Evaluation of intranasal administration of fluoroquinolones and their potential in the treatment of chronic rhinosinusitis: ciprofloxacin and levofloxacin

  2017cites this paper
• INTRANASAL DRUG DELIVERY SYSTEM “AN OVERVIEW”

  2017influential citation
• Nasal Drug Delivery of a Short Acting Hypnotic and Antimigraine Agent for the Treatment of Insomnia Associated Migraine

  2017cites this paper
• Development of Binary Composite Solid Microparticles for Improved Intranasal Absorption of Low Permeation Drug Molecules

  2017influential citation
• Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

  2017cites this paper
• Nasal Physiology and Drug Transport

  2017cites this paper
• Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage

  2016cites this paper
• A REVIEW ON NASAL DRUG DELIVERY SYSTEM FOR BRAIN TARGETING WITH RECENT ADVANCEMENT

  2016cites this paper
• Formulation and device design to increase nose to brain drug delivery

  2016cites this paper
• Medicinski proizvodi namijenjeni nazalnoj primjeni lijekova

  2016cites this paper
• Review Article Emerging Trends in Novel Drug Delivery System: Intra Nasal Drug Delivery

  2016cites this paper
• Delivery of Topical Therapies.

  2016cites this paper
• Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies

  2016influential citation
• Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain

  2016cites this paper
• Chitosan encapsulation modulates the effect of capsaicin on the tight junctions of MDCK cells

  2015cites this paper
• Influence of Dosage Form, Formulation, and Delivery Device on Olfactory Deposition and Clearance: Enhancement of Nose-to-CNS Uptake

  2015influential citation
• Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging

  2015cites this paper
• Chitosan: a propitious biopolymer for drug delivery.

  2015cites this paper
• Regional deposition of mometasone furoate nasal spray suspension in humans.

  2015cites this paper
• NASAL DRUG DELIVERY SYSTEM AN OVERVIEW

  2015cites this paper
• Chitosan in nasal delivery systems for therapeutic drugs.

  2014cites this paper
• Drug delivery across the nasal mucosa

  2014cites this paper
• Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.

  2014cites this paper
• NASAL DRUG DELIVERY SYSTEM: A REVOLUTIONARY OVERVIEW NASAL DRUG DELIVERY SYSTEM: A REVOLUTIONARY OVERVIEW NASAL DRUG DELIVERY SYSTEM: A REVOLUTIONARY OVERVIEW NASAL DRUG DELIVERY SYSTEM: A REVOLUTIONARY OVERVIEW

  2014cites this paper
• A REVIEW ON NASAL DRUG DELIVERY SYSTEM

  2014cites this paper
• International Journal for Pharmaceutical Research Scholars (IJPRS)

  2014cites this paper
• PREPARATION AND CHARACTERIZATION OF THERMOSENSITIVE MUCOADHESIVE IN_SITU GELS FOR NASAL DELIVERY OF ONDANSETRON HYDROCHLORIDE

  2014cites this paper
• Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

  2014cites this paper
• Factors involved in the design of nasal delivery systems for peptides and proteins

  2013cites this paper
• Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.

  2013cites this paper
• Thermally Triggered Mucoadhesive In Situ Gel of Loratadine: β-Cyclodextrin Complex for Nasal Delivery

  2013cites this paper
• Factores que intervienen en el diseño de sistemas de liberación nasal de péptidos y proteínas

  2013cites this paper
• Distribution of topical agents to the paranasal sinuses: an evidence‐based review with recommendations

  2013cites this paper
• Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

  2013cites this paper
• A Review on Intranasal Drug Delivery System

  2013cites this paper
• Physicochemical and physiological considerations for efficient nose-to-brain targeting

  2012cites this paper
• Preparation and evaluation of a thermosensitive hydrogel for the nasal delivery of insulin

  2012cites this paper
• Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

  2012cites this paper
• CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route

  2012cites this paper